|
Ronen brings with him a 14 years of marketing investor relations and communications experience from leading pharmaceutical and Biotechnology companies. Prior to joining Rosetta Genomics Ronen Tamir was Vice President Investor Relations for North America at Novartis AG. While Ronen was at Novartis Novartis significantly increased its North American shareholder base and Ronen’s team won numerous awards including the Best European IR Team in North America for 2005 by IR magazine the Silver Anvil award by the Public Relations Society of America and the Big Apple - Best of the Best award by the Institution of Public Relations both for Investor Relations campaign for 2006 . Prior to joining Novartis in 2004 Ronen held several key positions at Serono including Director of Business Intelligence for North America and Global Product Manager Neurology in Geneva Switzerland where he oversaw the global launch of Rebif® the leading therapy for Multiple Sclerosis. In addition Ronen was the Regional Product Manager for Neurology and Metabolism for Serono’s Intercontinental Business Operations. Ronen holds a degree in Biology from Bar-Ilan University in Israel and an MBA from Warwick Business School in the UK.
| 